Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05380024
Status:
UNKNOWN
Last Update Posted:
2022-08-18
First Post:
2022-05-13
Brief Title:
A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute